YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/β‐Catenin Signaling Pathway via Targeting NEK7
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Xiaoran Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, RNA-Binding Proteins, Wnt Signaling Pathway, NIMA-Related Kinases. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hebei Provincial Government-funded Provincial Medical Excellent Talent Project, Hebei Natural Science Foundation, Key R&D Program of Hebei Province.
Abstract (Originalsprache)
Objective
Gastric cancer remains a major global health burden. This study aimed to investigate the biological function, clinical significance, and underlying molecular mechanism of the RNA‐binding protein YTHDF3 in gastric cancer (GC) progression.
Methods
YTHDF3 expression was analyzed using public databases (TCGA, GEO), clinical GC specimens (IHC, RT‐qPCR), and GC cell lines. Functional roles were assessed through in vitro proliferation, migration, invasion, and apoptosis assays following YTHDF3 knockdown or overexpression, and via an in vivo subcutaneous tumor model. Mechanistic insights were gained through RNA sequencing, RIP‐qPCR, dual‐luciferase reporter assay, co‐immunofluorescence, rescue experiments, and western blotting to identify downstream targets and signaling pathways.
Results
YTHDF3 was significantly upregulated in GC tissues, correlating with lymph node metastasis and advanced TNM stage. In vitro, YTHDF3 knockdown inhibited GC cell proliferation, migration, and invasion while promoting apoptosis, whereas its overexpression had the opposite effects. In vivo, YTHDF3 knockdown suppressed tumor growth. Mechanistically, YTHDF3 directly bound to and stabilized NEK7 mRNA. NEK7 was highly expressed in GC and crucial for YTHDF3‐mediated oncogenic effects. Furthermore, YTHDF3 promoted GC progression by activating the Wnt/β‐catenin signaling pathway via NEK7, which was validated using a pathway inhibitor (IWR‐1‐endo).
Conclusion
This study identifies the YTHDF3/NEK7 axis as a key regulator of GC progression via activation of the Wnt/β‐catenin pathway. YTHDF3 represents a potential prognostic biomarker and a promising therapeutic target for GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University, Shijiazhuang, China.
- Gastroenterology Department, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
- Department of Infectious Diseases, The First Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Ting Liu, Jia Wang, Weifang Yu
Förderung
- Hebei Provincial Government-funded Provincial Medical Excellent Talent Project
- Hebei Natural Science Foundation
- Key R&D Program of Hebei Province
- Hebei Province County General Hospital Appropriate Health Technology Promotion Project
- Prevention and treatment of geriatric diseases by Hebei Provincial Department of Finance
- Spark Scientific Research Project of the First Hospital of Hebei Medical University
- Hebei Province Medical Applicable Technology Tracking Project
- Other projects of Hebei Province
Zitieren
APA
Sun, X., Chen, Y., Liu, K., Si, Y., Xuan, M., Zhang, R., Jiao, J., Liu, T., Han, S., Wang, J., & Yu, W. (2026). YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/β‐Catenin Signaling Pathway via Targeting NEK7. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70612
Vancouver
Sun X, Chen Y, Liu K, Si Y, Xuan M, Zhang R, et al. YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/β‐Catenin Signaling Pathway via Targeting NEK7. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70612
BibTeX
@article{Sun2026,
author = {Sun, Xiaoran and Chen, Yifan and Liu, Kunyi and Si, Yi and Xuan, Mingda and Zhang, Rui and Jiao, Jiao and Liu, Ting and Han, Shuangshuang and Wang, Jia and Yu, Weifang},
title = {YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/β‐Catenin Signaling Pathway via Targeting NEK7},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70612}
}
EUVIMED